my country's vaccine regulatory system has passed a new round of evaluation of WHO

The reporter learned from the State Drug Administration: The World Health Organization (WHO) announced on the 23rd that China passed the evaluation of the national regulatory system of vaccine.

The evaluation of WHO's national regulatory system is an important measure and effective means of evaluation of the national vaccine supervision capacity. It is a world -wide recognized international assessment that can scientifically evaluate a national vaccine supervision level. my country's vaccine regulatory system has passed the evaluation twice in 2011 and 2014. In July 2022, a new round of comprehensive evaluation was ushered in the WHO upgrade evaluation standard.

WHO's representative Gao Li said that the evaluation standards are more strict, the content is rich and comprehensive, and the indicators have increased significantly. China's vaccine regulatory system can be evaluated this time, which means that China has a stable vaccine regulatory system and can ensure that the quality of vaccines in production, importing or circulating in China can be controlled, safe, and effective.

China's assessment of the national regulatory system of vaccine is also an important foundation for vaccine exports worldwide. WHO will evaluate the vaccine regulatory system as the premise of purchasing the country's vaccine products, that is, only the national regulatory system can apply for the pre -certification of the WHO vaccine product and be included in the procurement list of international organizations such as the United Nations. In addition, the evaluation is also an important reference for registered and purchasing other countries for vaccine products.

Since the first assessment of the national regulatory system of the vaccine, there are multiple vaccines such as domestic B -type encephalitis, type I III spinal ash toxic inflammation, and hepatitis A vaccine, etc. Entering the international procurement list is purchased by the UNICEF, the Global Vaccine Immunization Alliance and other international institutions. Related products have been exported to dozens of countries and regions. Since the epidemic of new coronary pneumonia, three new coronary virus vaccines in my country have been included in the WHO emergency use list to help global resistance.

Huang Guo, deputy director of the State Drug Administration, said that the Chinese vaccine regulatory system through the WHO evaluation shows that my country's vaccine regulatory system is benchmarking the new standard of WHO and international advanced levels, and it has continued to strengthen and improve. This has also created good conditions for my country's vaccine to go abroad. In the future, my country can play a more positive role in the global vaccine supply, and make more contributions to promoting the available and burdensome of vaccines, especially developing countries, especially developing countries.

Source: People's Daily Online

- END -